Perfil da empresa · Healthcare

Apeloa Pharmaceutical Co Ltd

000739 · Shenzhen
País / Região
China
Data do IPO
9 de maio de 1997
Funcionários
6.787
Buffett Score
71/100
Forte
Valor de mercadoCN¥ 32,14 bi
Receita (TTM)CN¥ 9,16 bi
EBITDACN¥ 1,6 bi
Margem líquida9,28%
ROE12,75%
P/L (TTM)37,49
P/L projetado0
PEG0
LPACN¥ 0,74
Dividend yield1,42%
Faixa de 52 semanasCN¥ 14,70 – CN¥ 27,89

Dados da EODHD, apresentados na moeda de reporte; apenas para referência, não constitui recomendação de investimento.

Apeloa Pharmaceutical Co.,Ltd provides raw materials various pharmaceutical factories in the People's Republic of China and internationally. The company operates through API, CDMO, and Pharmaceutical segments. It offers API intermediates business, which includes cephalosporin, penicillin, psychotropic, cardiovascular and cerebrovascular, and veterinary API intermediates series; innovative drug R&D and production services CDMO include R&D services, commercial human drug projects, commercial veterinary drug projects and other commercial projects; pharmaceutical business includes anti-infective, cardiovascular, psychotropic, hepatobiliary and anti-tumor categories. The company also provides technology platforms, such as flow chemistry, synthetic biology and biocatalysis, crystallization and particle engineering, peptide, high potency compound, conjugate library service, oligonucleotide synthesis, and preparation and purification; and controlled-release formulation development, taste masking technology, and particle flow simulation. In addition, it exports its products under the Tianliwei, Baishixin, Li'an, Jutai, and other brands. Apeloa Pharmaceutical Co.,Ltd was founded in 1989 and is based in Dongyang, the People's Republic of China.

História

Em breveEsta seção está sendo preenchida — volte em breve.

Posição no setor

Em breveEsta seção está sendo preenchida — volte em breve.

Ainda não há análises sobre este ativo no seu idioma.